Bailey A. Martin-Giacalone

Bailey A. Martin-Giacalone

Auto-generated profile, based on publicly available information

Bailey A. Martin-Giacalone

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
HLHe Li
He Li
SSSaumya D Sisoudiya
Saumya D Sisoudiya
BMBailey A Martin-Giacalone
Bailey A Martin-Giacalone
MKMichael M Khayat
Michael M Khayat
SDShannon Dugan-Perez
Shannon Dugan-Perez
Philip LupoPhilip Lupo
Philip Lupo
Several cancer-susceptibility syndromes are reported to underlie pediatric rhabdomyosarcoma (RMS); however, to our knowledge there have been no systematic efforts to characterize the heterogeneous genetic etiologies of this often-fatal malignancy. We performed exome-sequencing on germline DNA from 615 patients with newly diagnosed RMS consented through the Children’s Oncology Group. We compared the prevalence of cancer predisposition variants in 63 autosomal-dominant cancer predisposition genes in these patients with population controls (n = 9963). All statistical tests were 2-sided. We identified germline cancer predisposition variants in 45 RMS patients (7.3%; all FOXO1 fusion negative) across 15 autosomal dominant genes, which was statistically significantly enriched compared with controls (1.4%, P = 1.3 × 10–22). Specifically, 73.3% of the predisposition variants were found in predisposition syndrome genes previously associated with pediatric RMS risk, such as Li-Fraumeni syndrome (TP53) and neurofibromatosis type I (NF1). Notably, 5 patients had well-described oncogenic missense variants in HRAS (p.G12V and p.G12S) associated with Costello syndrome. Also, genetic etiology differed with histology, as germline variants were more frequent in embryonal vs alveolar RMS patients (10.0% vs 3.0%, P = .02). Although patients with a cancer predisposition variant tended to be younger at diagnosis (P = 9.9 × 10–4), 40.0% of germline variants were identified in those older than 3 years of age, which is in contrast to current genetic testing recommendations based on early age at diagnosis. These findings demonstrate that genetic risk of RMS results from germline predisposition variants associated with a wide spectrum of cancer susceptibility syndromes. Germline genetic testing for children with RMS should be informed by RMS subtypes and not be limited to only young patients.

Verified
Journal Article
Open access
PDF file
BMBailey A. Martin-Giacalone
Bailey A. Martin-Giacalone
PWPhillip Weinstein
Phillip Weinstein
SPSharon E. Plon
Sharon E. Plon
Philip LupoPhilip Lupo
Philip Lupo
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children, yet little is known about its etiology. Studies that examine either environmental exposures or germline genetic predisposition in RMS have begun to identify factors that contribute to this malignancy. Here, we summarize epidemiological reports of RMS incidence in terms of several factors, including age at diagnosis, biological sex, and geographic location. We then describe findings from association studies, which explore the role of parental exposures, birth and perinatal characteristics, and childhood exposures in RMS. Further, we discuss RMS predisposition syndromes and large-scale sequencing studies that have further identified RMS-associated genes. Finally, we propose future directions of study, which aim to advance our understanding of the origin of RMS and can provide knowledge for novel RMS therapies.

15 March 2023 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
BMBailey A. Martin‐Giacalone
Bailey A. Martin‐Giacalone
ALAngela E. Lin
Angela E. Lin
SRSonja A. Rasmussen
Sonja A. Rasmussen
Russell S. KirbyRussell S. Kirby
Russell S. Kirby
ENEirini Nestoridi
Eirini Nestoridi
Philip LupoPhilip Lupo
Philip Lupo

20 May 2021 in Clinical Genetics
Verified
Journal Article
Open access
PDF file
NHNils R. Hebach
Nils R. Hebach
PCPilar Caro
Pilar Caro
BMBailey A. Martin‐Giacalone
Bailey A. Martin‐Giacalone
Philip LupoPhilip Lupo
Philip Lupo
FMFelix Marbach
Felix Marbach
CSChristian Schaaf
Christian Schaaf
Short stature is a common phenotype in children with Schaaf–Yang syndrome (SYS). Prader–Willi syndrome (PWS) and SYS share several phenotypic features including short stature, muscular hypotonia and developmental delay/intellectual disability. Evidence exists that similar to PWS, growth hormone (GH) deficiency may also be a feature of SYS. Recombinant human GH (rhGH) therapy has been approved for PWS, but the effects of rhGH therapy in individuals with SYS have not yet been documented. This retrospective, questionnaire-based study analyzes the prevalence of rhGH therapy in children with SYS, the effects of rhGH therapy on anthropometric measures, and parental perception of the treatment. Twenty-six individuals with SYS were sent a clinical questionnaire and a request for growth charts. We found a significant increase in height z-score (p* = 0.04) as well as a significant decrease in body mass index 6 months after rhGH therapy initiation (p* = 0.04). Furthermore, height z-scores of the treated group (mean z-score = −1.00) were significantly higher than those of the untreated group (mean z-score = −3.36, p = 0.01) at time of enrollment. All parents reported an increase in muscle strength and endurance, and several families noted beneficial effects such as improved cognition and motor development.

23 March 2023 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
PDF file
BMBailey A Martin-Giacalone
Bailey A Martin-Giacalone
MRMelissa A Richard
Melissa A Richard
MSMichael E Scheurer
Michael E Scheurer
JKJaved Khan
Javed Khan
PSPagna Sok
Pagna Sok
Philip LupoPhilip Lupo
Philip Lupo
Relative to other pediatric cancers, survival for rhabdomyosarcoma (RMS) has not improved in recent decades, suggesting the need to enhance risk stratification. Therefore, we conducted a genome-wide association study for event-free survival (EFS) and overall survival (OS) to identify genetic variants associated with outcomes in individuals with RMS. The study included 920 individuals with newly diagnosed RMS who were enrolled in Children’s Oncology Group protocols. To assess the association of each single nucleotide polymorphism (SNP) with EFS and OS, we estimated hazard ratios (HRs) and 95% confidence intervals (CIs) using multivariable Cox proportional hazards models, adjusted for clinical covariates. All statistical tests were two sided. We also performed stratified analyses by histological subtype (alveolar and embryonal RMS) and carried out sensitivity analyses of statistically significant SNPs by PAX3/7-FOXO1 fusion status and genetic ancestry group. We identified that rs17321084 was associated with worse EFS (HR = 2.01, 95% CI = 1.59 to 2.53, P = 5.39 × 10−9) and rs10094840 was associated with worse OS (HR = 1.84, 95% CI = 1.48 to 2.27, P = 2.13 × 10−8). Using publicly available data, we found that rs17321084 lies in a binding region for transcription factors GATA2 and GATA3, and rs10094840 is associated with SPAG1 and RNF19A expression. We also identified that CTNNA3 rs2135732 (HR = 3.75, 95% CI = 2.34 to 5.99, P = 3.54 × 10−8) and MED31 rs74504320 (HR = 3.21, 95% CI = 2.12 to 4.86, P = 3.60 × 10−8) were associated with worse OS among individuals with alveolar RMS. We demonstrated that common germline variants are associated with EFS and OS among individuals with RMS. Additional replication and investigation of these SNP effects may further support their consideration in risk stratification protocols.

1 April 2025 in JCO Precision Oncology
Verified
Journal Article
Open access
AAAkila Anandarajah
Akila Anandarajah
HDHank Dart
Hank Dart
BMBailey Martin-Giacalone
Bailey Martin-Giacalone
MBMelinda Bachini
Melinda Bachini
BDBettina Drake
Bettina Drake
ELErin Linnenbringer
Erin Linnenbringer